The global dementia drugs market is estimated to grow at a significant CAGR during the forecast period. In recent years there has been a lot of progress in terms of developing drugs for dementia utilizing various approaches. For instance, the new approaches include moving on from a target-centric approach to innovative molecular probes that includes the study of changing the level of the proteins and many more. The innovative and new approach adopted in the drug development of dementia is anticipated to drive the global dementia drug market considerably. 
Get Free Sample Copy @ https://www.omrglobal.com/request-sample/dementia-drugs-market
Additionally, the engagement of key market players and renowned institutes such as UCLA and Oxford in the drug development will also impact the global dementia drug market size. In addition, neurodegenerative disorders such as dementia and its associated conditions including Alzheimer's disease and Parkinson's disease are characterized by the accumulation and aggregation of misfolded proteins. Hence, a great emphasis on the studies related to how the cells respond to the misfolded proteins, and its process called unfolded protein response is being given for the drug development. For instance, the research on misfold protein is also taking place at the University of Cambridge which is anticipated to drive the dementia drug industry significantly during the forecast period. 
A Full Report of Global Dementia Drugs Market is Available at: https://www.omrglobal.com/industry-reports/dementia-drugs-market
However, apart from the new approaches, the main target for the dementia drug development has been on treatments that focus on amyloid accumulation. Hence, the availability of BACE inhibitors and various antibodies targeting beta-amyloid in the brain is increasing the potential of detention drug market share. Moreover, the roles of various parts of the brain such as astrocytes and microglia and neuroinflammation have also been discovered in some recent studies. The better understanding of astrocytes and microglia and neuroinflammation in dementia will also present new opportunities for the dementia drug industry growth. In addition to this, the treatment approaches that combine more than one dementia drugs will also drive the market during the forecast period.
Dementia Drugs Market- Segmentation
By Type of Dementia
Lewy Body Dementia
Parkinson’s Disease Dementia
Alzheimer's Disease
Others
By Type of Drugs
Cholinesterase Inhibitors
MAO Inhibitors
Glutamate Inhibitors
Others
Dementia Drugs Market- Segment by Region 
North America           
US
Canada
Europe
Germany
UK
France
Spain
Italy
Rest of Europe
Asia-Pacific    
China
Japan
India
Rest of Asia-Pacific
Rest of the World
Latin America
Middle East Africa
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/dementia-drugs-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404